IPO

Infinium Pharmachem Limited IPO

NSE SME

Listed On: Apr 17, 2023 at ₹ 141.5

₹ 270000 /2000 Shares
*Min Investment

Check Allotment

31 Mar, 2023

Open Date

05 Apr, 2023

Close Date

11 Apr, 2023

Allotment Date

17 Apr, 2023

Listing Date
Infinium Pharmachem Limited IPO Live Subscription Details
Retail 1.86x
NIIs 1.80x
Retail 1.86x
Total 1.84x
Last updated: 05 Apr 2023,05:00:00 PM
Infinium Pharmachem Limited IPO Issue Details
  • Issue Price ₹135 per equity share
  • Face Value ₹10 Per Equity Share
  • Issue Price 1,875,000 shares(aggregating up to ₹25.31 Cr)
  • Listing at NSE SME
  • List Price 141.5
  • Listing Date 2023-04-17
  • Lead Manager Swastika Investmart Ltd
  • Registrar Bigshare Services Pvt Ltd
Infinium Pharmachem Limited IPO Details
  • Retail Portion N/A
Infinium Pharmachem Limited IPO Documents
Infinium Pharmachem Limited IPO Details


Infinium Pharmachem Limited IPO is an SME IPO, priced at ₹135 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform.

The IPO bidding window is open from Mar 31, 2023 to Apr 5, 2023. The allotment is expected to be finalized on Apr 11, 2023, and the tentative listing date is Apr 17, 2023.


The registrar of the IPO is Bigshare Services Pvt Ltd, and

Read More
Infinium Pharmachem Limited IPO Subscription Analysis And Details
Retail
1.86x
Total
1.84x
As onQIB / NIIRetailTotal
Shares Offered / Reserved870,000870,0001,740,000
Day 1 31-03-23 06:00 PM
0.06 x0.10 x0.10 x
Day 2 03-04-23 06:00 PM
0.33 x0.60 x0.46 x
Day 3 05-04-23 06:00 PM
1.80 x1.86 x1.84 x
Infinium Pharmachem Limited Valuations
Earnings Per Share (EPS) ₹60.07/-
P/E Ratio N/A
RoNW 43.85%
Net Asset Value (NAV) - Post Issue ₹123.45/-
Infinium Pharmachem Limited Company Financials
In Lakhs
In Lakh
30-Sept-2231-Mar-2231-Mar-2131-Mar-20
Assets7,075.715,899.953,418.272,244.60
Revenue7,985.3910,005.257,115.373,941.64
Profit After Tax551.01610.64272.4893.40
About Infinium Pharmachem Limited Company

Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.

The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.

Infinium Pharmachem's manufacturing plant is located in Gujarat - INDIA, which spans across 4100 Sq. Mtr. Plot area. The facility is FDA certified & GMP compliant with capabilities of producing complex Iodine Derivatives.

The company serves to over 15+ countries across the globe and has over 200+ Iodine Derivatives and 7+ APIs.

Read More
Infinium Pharmachem Limited - Promoter(s)

Mr. Sanjaykumar Viththalbhai Patel

r. Pravin Bhadabhai Madhani

Mr. Mitesh Lavjibhai Chikhaliya

Pre Issue Share Holding : 100%

Post Issue Share Holding : %

Infinium Pharmachem Limited IPO - Issue Objectives
1

Marketing and branding expenses (including registration in reach - Europe, and other marketing expenses).

2

Repayment of some of the existing loans and expansion of units.

3

To meet incremental working capital requirements.

4

To meet public issue expenses.